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ABSTRACT 
 The Canadian Association of Gastroenterology (CAG) implemented the 
Colonoscopy Skills Improvement (CSI) program across Canada with the goal of 
improving colonoscopy quality. The objective of this study was to assess the impact of 
the CSI program on colonoscopy quality in St. John's, NL. 
 Nineteen endoscopists practicing in a tertiary referral centre who have 
participated in CSI training since October 2014 were evaluated. For each endoscopist 
fifty consecutive procedures immediately before, immediately after, and eight months 
following CSI training were included. The primary outcome was change in adenoma 
detection rate (ADR). Secondary outcomes included number of adenomas detected per 
colonoscopy (APC), cecal intubation rate, and sedative usage and dosing. 
 Patient characteristics were similar between time points. ADR did not 
significantly improve immediately after CSI training (31.8% v. 33.6%, p=0.484) or at the 
eight-month assessment (31.8% v. 35.3% p=0.107). There was no significant change in 
APC or completion rate at any time point. There was a statistically significant decrease in 
the average dose of Fentanyl (72.8mcg v. 64.8mcg v. 63.5mcg, p<0.001) and Midazolam 
(2.49mg v. 2.17mg v. 2.11, p<0.001) immediately after CSI training that persisted at 
eight months. 
 Participation in the CSI program is not associated with change in ADR. CSI 
training is associated with decreased sedation dosing during colonoscopy. 
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CHAPTER 1 INTRODUCTION 
 
1.1 Colorectal Cancer (CRC) 
 Colorectal cancer is a common and lethal disease. Globally, it is the third most 
commonly diagnosed cancer in males and the second in females. 1 In Canada, it is the 
second leading cause of cancer death in men and the third leading cause of cancer death 
in women. There will be an estimated 26 800 new CRC diagnoses in Canada during 2018 
and approximately 9400 of those will die from it. 2 The risk of developing CRC increases 
with age, with more than 90% of diagnoses being made in patients older than 50 years.3 
 Colorectal cancers arise from colorectal polyps, which are abnormal collections of 
cells originating from the lining of the colon or rectum. Colonic polyps may be neoplastic 
or non-neoplastic and are classified based on histologic type. Adenomas are the most 
common type of neoplastic polyps and have potential to develop into CRC. The most 
common non-neoplastic polyps are hyperplastic and hamartomatous polyps. 
 Transformation of a polyp to a cancer happens through the well-described 
adenoma-carcinoma sequence. 4 Simply put, this sequence is a stepwise pattern of 
mutational activation of oncogenes and inactivation of tumor suppressor genes that 
results in cancer formation. The adenoma-carcinoma sequence is thought to progress over 
eight to ten years in most cases. Removal of adenomatous polyps early in this sequence 
can prevent cancer development. 
 Colorectal cancer occurs in hereditary, sporadic, and familial forms. Hereditary 
CRC is characterized by a history of CRC in other family members, a young age at onset, 
and genetic defects that lead to a propensity for cancer in multiple organ systems. Two 
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extensively studied hereditary colorectal cancer syndromes include familial adenomatous 
polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC). These account 
for 5-10% of all colon cancers. 
 FAP is an autosomal dominant genetic condition in which affected individuals 
develop hundreds to thousands of adenomatous polyps in the colon. Polyps begin 
developing as early as the teenage years and will almost invariably become malignant 
over time. The average age at which an individual with FAP develops colon cancer is 39 
years. 3 The lifetime colorectal cancer risk approaches 100% in individuals with FAP. 
These patients are also at risk for developing duodenal adenomas and gastric polyps. 
Genetic testing for FAP is available and once diagnosed, surgical removal of the entire 
colon and rectum (proctocolectomy) is recommended. 
 HNPCC, also known as Lynch syndrome, is an autosomal dominant disorder that 
carries a 70-80% lifetime risk of developing colon cancer and a 30-60% risk for 
developing endometrial cancer in women, as well as increased risk for multiple other 
cancers. 3 Clinically these patients have only a small number of colorectal polyps found 
on colonoscopy. The increased cancer risk is due to inherited mutations that impair DNA 
mismatch repair. Clinical scoring systems, such as the Amsterdam criteria, are used to 
identify high-risk individuals for genetic testing, which can establish a diagnosis of 
Lynch syndrome. 5 Once diagnosed, these individuals can be entered into an appropriate 
screening program. 
 Familial colon cancers account for 15-30% of all CRC cases. For familial 
colorectal cancer, lifetime risk increases for members of families in which the index case 
is young (<50 years) and the relative is closely related (first-degree). 3 Risk for these 
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cancers increases as the number of family members with colorectal cancer rises. 
Individuals who have a first-degree relative diagnosed with CRC before age 50 have a 
two fold increased risk for colon cancer. 
 Familial CRC constitutes a heterogeneous group of patients in whom the 
underlying molecular mechanism is still unknown. Predisposition to developing CRC in 
this setting is possibly due to common low-penetrance genetic components but the role of 
genetic testing in clinical practice has yet to be determined. 6 Novel genes and syndromes 
have been described which account for a small proportion of patients who have a 
phenotype/family history suggestive of a genetic syndrome including 'polymerase 
proofreading-associated polyposis' and mutations in the NTHL 1 gene.7 
 Sporadic colorectal cancers affect an older population (60 - 80 years of age) and 
occur in the absence of a family history, the key component separating them from 
familial cancers. Approximately 60-80% of all colon cancers occur sporadically. 
Sporadic colorectal cancers develop from neoplastic polyps through the adenoma-
carcinoma sequence. 3 Genetic mutations associated with sporadic cancers are limited to 
the tumor itself, unlike in hereditary disease, in which a specific mutation is present in all 
cells of the affected individual. 3 Sporadic cancers result from somatic mutations, which 
are genetic alterations to a cell that can be passed on to the progeny of the mutated cell. 
Germ line mutations are inherited genetic alterations that occur in the germ calls (i.e., 
sperm and eggs). 
 Multiple other risk factors for colon cancer include obesity, inactivity, alcohol 
consumption, cigarette smoking, diet high in processed meats, diet low in fibre and 
inflammatory bowel disease.2 
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1.2 Colonic Polyps 
 Colonic polyps can be broadly classified into categories including adenomatous, 
inflammatory, hamartomatous, and serrated. It can be difficult to distinguish the type of 
polyp endoscopically, warranting removal for histologic examination.  
 The most prevalent neoplastic polyp is the adenoma, which can be subcategorized 
as tubular, villous and tubulovillous. 8 Risk factors for developing colorectal adenomas 
include increasing age, increased body mass index (BMI) and male gender. Some degree 
of dysplasia exists in all adenomas. Adenomatous polyps are classified histologically as 
having low-grade dysplasia or high-grade dysplasia. High-grade dysplasia is synonymous 
with intraepithelial carcinoma and represents an intermediate step in the progression from 
low-grade dysplasia to cancer. The incidence of invasive carcinoma being found in an 
adenoma is dependent on the size and histologic type of polyp. Only a small number of 
adenomas (five percent or less) progress to cancer. Advanced adenomas, defined as being 
≥ 10mm in size, containing villous components or evidence of high-grade dysplasia, 
carry higher risk of progression. Adenomas should be resected completely when 
identified and published guidelines define follow up. 
 Inflammatory polyps are non-neoplastic intraluminal projections of mucosa 
consisting of stromal and epithelial components and inflammatory cells. Hamartomatous 
polyps, also non-neoplastic, are made up of tissue elements that are normally found at the 
site but are growing in a disorganized fashion.  
 Serrated polyps are a heterogeneous group of polyps with variable malignant 
potential. They include hyperplastic polyps, traditional serrated adenomas and sessile 
serrated polyps (with or without dysplasia). 9 Classification of serrated polyps is evolving 
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and variation exists among pathologists. Hyperplastic polyps are the most common non-
neoplastic polyps of the colon. Hyperplastic polyps and are usually less than 5mm in size 
and are composed of cells showing dysmaturation and hyperplasia. They are typically 
located in the recto-sigmoid colon and can be biopsied for diagnosis, but require no 
specific follow up, as they have no potential to progress to adenocarcinoma. 
 Sessile serrated polyps (SSP) and traditional serrated adenomas (TSA) are often 
flat and coated with mucous making them difficult to identify endoscopically. 10 These 
polyps frequently exhibit dysplasia. SSPs are considered the likely precursor lesions to 
sporadic microsatellite instability colon cancer. 11 These polyps should be removed when 
identified with follow up as per published guidelines. There is evidence that these lesions 
may progress more quickly through the adenoma-carcinoma sequence, following an 
alternative pathway, and therefore disproportionally contribute to interval CRCs. 12 
Interval CRC may be defined as "a colorectal cancer diagnosed after a screening or 
surveillance exam in which no cancer is detected and before the date of the next 
recommended exam. 13" Serrated polyposis syndrome (SPS) is a rare condition 
characterized by multiple large and/or proximal serrated polyps. The genetic basis of SPS 
remains unknown and current data support the existence of more than one genetic cause. 
Both sporadic and hereditary cases have been described.11 
 Traditional serrated adenomas are the least common type of serrated polyps, are 
more prevalent in the rectosigmoid colon and may be pedunculated or sessile. TSAs have 
diffuse, but often mild, cytologic dysplasia. They are thought to be likely precursor 
lesions to the biologically aggressive, BRAF mutated, microsatellite stable, colorectal 
cancer.14 
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 A variety of submucosal lesions including lymphoid aggregates, lipomas, 
leiomyomas, fibromas, polypoid endocrine tumors, rectal carcinoids and metastatic 
lesions may impart a polypoid appearance to the overlying colonic mucosa. The most 
common of these, the lipoma, can be diagnosed endoscopically. 
 Morphologically, colorectal polyps arising from the intestinal mucosa are 
classified as pedunculated or sessile. Pedunculated polyps are on a stalk arising from the 
mucosa and sessile polyps are flat lesions without a stalk. 3 The Paris classification 
system was developed to describe polyp morphology. 15 The clinical implications of the 
Paris classification mainly involve the assessment of endoscopic resectability. The NICE 
classification is based on narrow-band images of polyps and uses staining, vascular 
patterns, and surface pit patterns to distinguish between hyperplastic and adenomatous 
polyps. 16 The Kudo pit pattern was also developed to predict polyp histology based on 
surface pit patterns. 17 Using such standardized descriptors is encouraged for synoptic 
reporting.18 
 Some challenges exist for detecting and removing polyps from the colon. Good 
colonic preparation prior to the exam is essential and a meticulous inspection by an 
experienced endoscopist provides the best results. Significant miss rates for detecting 
polyps (up to 28%), including adenomas, have been described in studies comparing back 
to back procedures. Specifically, small flat polyps are often associated with a higher miss 
rate. 19 We also know that screening colonoscopy is less effective at reducing the 
incidence of proximal colorectal cancers when compared to distal cancers. 20 Some 
proximal colon cancers may also be more biologically aggressive tumors, such as those 
that arise from HNPCC carriers. 
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1.3 Screening for CRC 
 For the purpose of colorectal cancer screening, the population is divided into 
average risk and high-risk individuals. High-risk individuals are those with a family 
history of CRC at a young age, a personal history of CRC or adenomas, inflammatory 
bowel disease and some inherited syndromes. For individuals in the high-risk group, 
screening guidelines exist based upon patient risk factors and require periodic 
colonoscopy.21,22 
 Average risk individuals are those aged 50-74 years and without high-risk 
features. Current recommendations are for a stool test every one to two years, which 
should be followed up by a colonoscopy if positive. 21 Stool tests include the guaiac-
based fecal occult blood test (gFOBT) and the fecal immunochemical test (FIT). The 
gFOBT test is able to detect small amounts of blood in the stool and is slightly different 
than the FIT test, which uses specific antibodies to detect blood in the stool. The FIT test 
is a more sensitive screening tool than the gFOBT test but they have similar specificity. 
 
1.4 Colonoscopy 
 Following pioneering work of Dr. Niwa and Dr. Yamagata, Dr. William Wolff 
and Dr. Hiromi Shinya invented the colonoscope in 1969. 23 These procedures were done 
looking through an eyepiece at the end of a scope. In 1983 the video endoscope was first 
introduced, enabling viewing of an image on a video screen. Multiple companies 
manufacture colonoscopes today including Karl Storz, Fujinon, Pentax and Olympus. 
 Colonoscopy is the endoscopic examination of the large bowel and the distal part 
of the small bowel with a camera on a flexible tube passed through the anus. It can 
 8 
provide a visual diagnosis and grants the opportunity for biopsy or removal of suspicious 
lesions. Common indications for colonoscopy include gastrointestinal hemorrhage, 
unexplained changes in bowel habit and suspicion of malignancy. It is also used as a 
screening test for colon cancer. The day before, and sometimes the morning of, a 
colonoscopy the patient takes an oral laxative solution to cleanse the bowel. Colonoscopy 
frequently requires sedation, so may be performed as an outpatient procedure if the 
patient has an adult to accompany them.24 
 The procedure is performed with the patient recumbent, usually in the left lateral 
decubitus position. A colonoscope is inserted through the anus to the rectum and 
advanced through the colon. This is completed using dials that allow for deflection of the 
tip of the instrument, which includes a video chip to produce an image onto a screen. Air 
or carbon dioxide is inflated to stretch the large intestine and allow easier visualization 
while the colonoscope is slowly removed while performing meticulous inspection of the 
mucosa. There is one working port at the end of the scope that allows for the introduction 
of smaller devices to perform various interventions, such as taking a biopsy or removing 
a polyp. Photographs and videos can also be taken to document findings. Colonoscopy 
usually takes about 30 minutes to perform depending upon patient anatomy and findings. 
There is usually an endoscopy nurse present to assist the endoscopist during the 
procedure. 
 Complications of colonoscopy include complications related to the bowel 
preparation, the procedure itself, and to the use of sedative agents. Dehydration, patient 
discomfort and transient hypoxia are not uncommon. Post-polypectomy bleeding and 
colonic perforation (a hole in the large intestine) are rare but serious complications. 
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Patients are advised to present to the nearest emergency department for assessment if 
they develop severe abdominal pain or experience prolonged rectal bleeding. 
 
1.4.1 Quality in Colonoscopy 
 Quality improvement for colonoscopy has been a recent focus in the endoscopy 
community. Colonoscopy plays a critical role in the early detection and prevention of 
CRC with a number of quality indicators identified. 25-28 Only adenoma detection rate 
(ADR) has been clearly associated with risk of interval CRC and death. 29,30 ADR may be 
defined as "the fraction of patients undergoing colonoscopy who had one or more 
adenomas detected. 31" Other intra-procedure quality indicators have been identified 
including adequacy of bowel preparation, cecal intubation rate, patient comfort, 
withdrawal time and sedation use.25 
 Given variation in colonoscopy quality metrics among endoscopists, the Canadian 
Association of Gastroenterology (CAG) developed the Skills Enhancement for 
Endoscopy (SEE) program. 32 This program consists of three separate types of accredited 
programs: Train-the-Endoscopy-Trainer (TET), Colonoscopy Skills Improvement (CSI) 
and the Endoscopic Polypectomy Improvement Course (EPIC). 
 The TET program is designed to improve teaching skills and procedural 
conscious competence needed to teach endoscopy. Courses are led by SEE faculty and 
run for one and a half days with an instructor to student ratio of 1:3. The CSI program, 
which runs for one day, is designed to provide up-skilling for practicing colonoscopists. 
This is targeted towards endoscopists participating in provincial colon cancer screening 
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programs. Participants get hands on colonoscopy training under supervision with an 
instructor to student ratio of 2:3. 
 Traditionally and often presently, the teaching of colonoscopy is performed by 
instructors who were self-taught using a trial and error approach to skills acquisition with 
little time for self-reflection or formative feedback. 33 Given this training model, these 
instructors struggle teaching colonoscopy as they failed to develop the tools needed to 
deconstruct what happens during a colonoscopy. That is, they failed to become 
consciously competent colonoscopists. Conscious competence originates from the 'Four 
stages for Learning Any New Skill,' a theory developed in the 1970s by psychologist 
Noel Burch. According to this theory, learning progresses from unconscious 
incompetence through conscious incompetence and conscious competence to 
unconscious competence. Prior to the SEE program, many colonoscopists became 
unconsciously competent without first becoming consciously competent. The SEE 
program strives to develop conscious competence in its trainees such that these 
individuals can better describe colonoscopy to others.  
 Coaching is a proven approach for performance improvement in both surgery and 
professional sports. Basic principles of facilitated learning, autonomous and 
individualized goal setting and constructive feedback can apply to both trainees and 
surgeons in practice. 34 This can be applied for the most simple or complex procedures 
depending on the level of the trainee. The CSI program follows many of the same 
principles to improve performance in colonoscopy, with CSI faculty functioning as 
coaches to participants. Faculty observe and critique procedures and provide constructive 
feedback on technique in a non-confrontational manner. 
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1.5 Purpose 
 A study showing poorer than expected safety outcomes following colonoscopy in 
St. John's, NL, along with the launch of the provincial colon cancer screening program, 
prompted Eastern Health to join the CAG SEE program. Training in St. John's has been 
ongoing since 2014. 35 The purpose of this study was to evaluate the CAG CSI course as 
an educational intervention to improve colonoscopy quality in St. John's, NL. The 
primary outcome was change in endoscopist ADR. Secondary outcomes included APC, 
cecal intubation rate, sedation usage and dosing and withdrawal time. 
 
Null Hypothesis 
 H0: CSI training has no effect on ADR. 
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CHAPTER 2 REVIEW OF LITERATURE/BACKGROUND 
 
2.1 Quality Measures in Colonoscopy 
 Quality indicators or measures are tools that help to quantify healthcare processes. 
26 They allow researchers to quantify processes, facilitating analysis and comparison of 
the results of various interventions. Common quality indicators include: adenoma and 
polyp detection, cecal intubation, withdrawal time, bowel preparation, medication usage 
and patient comfort. 
 An important outcome measure after colonoscopy is the prevention of colorectal 
cancer (CRC), however, cancer occurrences are so infrequent that their use is limited as a 
quality indicator. Adenoma detection, which correlates well with colorectal cancer 
prevention, is used as an outcome measure.26 
 
2.1.1 Adenoma & Polyp Detection 
 For screening colonoscopy in average risk individuals, ADR performance targets 
are ≥25% for all patients (≥30% for men and ≥20% for women). 25 These thresholds were 
chosen based on the prevalence rate of adenomas detected in screening colonoscopy 
programs. ADR for a particular endoscopist can be determined by including both 
screening/surveillance and diagnostic procedures but minimum acceptable standards have 
been developed using primarily screening/surveillance procedures. Studies have found 
that endoscopists’ ADR is significantly associated with the risk of interval cancer and 
death. 29,30 In fact, ADR is the only quality indicator that has been shown to be directly 
associated with interval CRC. 27 Each one percent increase in ADR has been associated 
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with a three percent decrease in the risk of interval cancer development. 29 Suggestions to 
explain interval cancer development have included missed lesions, new lesions, and 
incompletely resected lesions. Improvement in training and a creating a culture of quality 
improvement are cited as potential solutions.36 
 Polyp detection rate (PDR) is a surrogate for ADR that is easier to measure 
because it does not require histological review. 37 Although PDR correlates with ADR, it 
is a less desirable measure. PDR will include polyps with histologies that are benign and 
inconsequential. An additional problem with focusing quality improvement on PDR is the 
possibility that endoscopists inflate their PDR by intentionally removing small and 
clearly inconsequential polyps. 25 PDR is not currently endorsed as a quality indicator. 25 
Adenoma per colonoscopy (APC) is another metric that may more accurately reflect 
inspection of the entire length of the colon and provide greater separation between 
endoscopists than ADR. 38 APC is calculated by dividing the total number of adenomas 
detected by the total number of colonoscopies performed. APC has not yet been shown to 
have a direct association with decreased interval CRC. The remainder of this section 
focuses on other quality indicators that are important but have not yet been associated 
with interval CRC. 
 
2.1.2 Cecal Intubation  
 Cecal intubation is defined as passage of the colonoscope tip to a point proximal 
to the ileocecal valve so that the entire cecal caput is visible. A colonoscopy is only 
considered complete if the colonoscope is passed into the cecum. Confirmatory photo 
documentation and description of cecal landmarks should be done for each procedure. 
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 Variations in cecal intubation rates exist in practice; inadequate cecal intubation 
could explain the proximal location of some interval cancers. 26 Indeed, cecal intubation 
rates below 80% have been associated with higher rates of interval proximal colon 
cancer. 39 Colonoscopists should be able to intubate the cecum in ≥90% of all cases and 
≥95% of cases when the indication is screening in a healthy adult.25 
 
2.1.3 Withdrawal Time 
 Mean withdrawal time for colonoscopies with normal results in a patient with 
intact anatomy should be greater than or equal to six minutes. 25 Studies have shown that 
a six minute minimum withdrawal time is associated with increased detection of 
significant neoplastic lesions. It is the minimum recommended time to conduct a 
thorough inspection of the colonic mucosa. Many studies that have examined the 
association between withdrawal time and quality were limited as they were performed in 
single centers with relatively few endoscopists. 26 Consequently, there is potential for 
further research to define optimal withdrawal time. 
 The primary utility of recording withdrawal time may be in correcting 
performance of colonoscopists with substandard ADRs. 40 In a study comparing 
endoscopists before and after instituting a minimum eight minute withdrawal protocol, 
ADR improved. Endoscopists with the highest rates of adenoma detection were those 
with intermediate mean withdrawal times. Furthermore, increases in ADR were apparent 
among all endoscopists whose baseline rates were at the low end of the spectrum.40 
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2.1.4 Bowel Preparation 
 Quality of bowel preparation directly impacts adenoma detection. Adequate 
preparation is critical to ensure full inspection of the colonic mucosa. There are several 
validated scales to rate preparation quality however none are widely adopted. As a 
general rule, if the preparation is inadequate to identify polyps greater than five 
millimeters in size, then the procedure should be repeated. Most centers use a Likert scale 
when describing preparation quality, rating preparations as: excellent, good, poor or very 
poor. 
 Preparations rated poor or very poor warrant an early repeat examination. A meta-
analysis conducted in 2014 determined that poor preparation yielded significantly lower 
ADR than intermediate and high quality preparation but that each of the latter did not 
differ significantly from one another. 41 Poor preparation is also associated with 
prolonged cecal intubation and withdrawal times.25 
 Recently, split dosage bowel preparations have become common. Split dosage 
refers to taking half the dose of purgative the night before the exam and the second half 
the morning of the exam. Previously it was more common to administer the entire 
preparation the day before a colonoscopy and have the patient consume only clear fluids 
until their procedure. Split dosage bowel preparation has been found to improve ADR as 
well as preparation quality and colonoscopy completion rate. 42 Split dose bowel 
preparation is now considered the standard of care. 
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2.1.5 Medication Usage and Patient Comfort 
 There is great variation in the use of sedation and analgesia among 
colonoscopists. 27 Traditionally, colonoscopy has been performed using conscious 
sedation with a combination of a narcotic and a benzodiazepine. In this scenario the 
endoscopist is in control of medications administered by a nurse. In many countries, a 
large proportion of colonoscopies are now performed with little or no sedation. 43 There 
has been a recent trend in North America towards increased use of deep sedation for 
colonoscopy. This is often done using propofol and may negatively affect safety and 
quality while offering marginal benefits. 44 In North America propofol administration is 
usually done with anesthesia assistance. 
 The American Society of Anesthesiologists has defined a continuum of sedation 
including minimal, moderate, deep sedation and general anesthesia. Minimal sedation is a 
drug-induced relief of apprehension with minimal effect on consciousness. The patient is 
awake and alert. Moderate sedation (often referred to as conscious sedation) is a 
depression of consciousness in which the patient can respond purposefully to verbal or 
light tactile stimuli. Airway reflexes, spontaneous ventilation and cardiovascular function 
are maintained. Deep sedation is a depression of consciousness in which the patient 
cannot be aroused by voice or light touch but responds purposefully to repeated or painful 
stimuli. The patient may not be able to maintain airway reflexes or spontaneous 
ventilation but cardiovascular function is usually maintained. General anesthesia is a state 
of unconsciousness. Airway intervention is often required and cardiovascular function 
may be impaired.45,46 
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 No direct association had been demonstrated between sedation usage and ADR 
but there is some suggestion that sedation can improve colonoscopy completion. 47 This is 
believed to be facilitated by improved patient comfort, which has been associated with 
improved cecal intubation, though there are conflicting reports.48 
 While sedation is used to improve patient comfort, optimal colonoscopic 
technique may also improve patient comfort and minimize sedation requirements. 
According to a recent study from the UK screening program, the medication practices of 
individual colonoscopists does not appear to be related to the occurrence of significant 
discomfort among patients.49 
 There has been recent interest in the type and level of sedation used for 
colonoscopy given the trend towards increased propofol usage in North America. Patient 
reported outcomes in terms of comfort and satisfaction were highlighted in a meta-
analysis that suggested improved overall satisfaction with propofol sedation when 
compared to traditional agents. 50 Propofol has also been shown to have faster patient 
recovery and discharge times when compared to traditional agents. 
 Type of sedation may impact safety during colonoscopy procedures. Use of 
propofol provides deep sedation as opposed to the traditional narcotic and 
benzodiazepine combination, which provides mild-to-moderate sedation. Deep sedation 
for colonoscopy has recently been described as unnecessary and wasteful, citing 
increased cost, marginal benefits in comfort and negative impacts on safety and quality as 
justification. 44 Although studies have shown no difference in cardiopulmonary events 
when comparing propofol with traditional sedative agents, use of an anaesthesiologist has 
been associated with increased risk of serious but uncommon events. 51-53 The use of an 
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anaesthesiologist, who typically provides propofol sedation, has been associated with 
increased risk of perforation, haemorrhage, pneumonia and stroke. Deep sedation may 
also impair the endoscopist’s ability to use optimal colonoscopy technique including 
prescribed patient position changes and water exchange. Deep sedation may prevent 
patients from expressing pain caused by excessive bowel distension and hence increase 
their risk of perforation. 
 
2.2 Specialty and Experience 
 Studies have shown that gastroenterologists have higher ADRs than endoscopists 
from other specialties, such as surgeons, internists and family physicians. 54 However 
others have suggested that endoscopist annual procedural volume of greater than 200 
colonoscopies per year may actually be more important than specialty when considering 
quality measures such as ADR, polyp detection and cecal intubation.54-56 
 The teaching of endoscopy can vary significantly based on specialty. In most 
major Canadian hospitals both gastroenterology fellows and general surgery residents 
learn colonoscopy as part of their training. Gastroenterology fellows undergo two years 
of training and typically get exposed to a higher case volume than their general surgery 
counterparts. General surgery residents typically have three to five months of dedicated 
endoscopy training and exposure to colonoscopy outside of that is variable. A study done 
in Western Canada in 2008 showed gastroenterology fellows performed an average of 
248 colonoscopies during their training whereas general surgery residents performed an 
average of just 91 colonoscopies. 57 The American Society for Gastrointestinal 
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Endoscopy recommends that a minimum of 140 colonoscopies be performed to assess 
competency. 
 It is well recognized that completion of a specified number of colonoscopies does 
not necessarily imply competence. However, volume and accreditation have been shown 
to be more important than specialty in determining quality standards for colonoscopy for 
practicing endoscopists.58A recent study showed non-gastroenterologist specialty as a risk 
factor for perforation but cited that this result likely reflects volume and training style. 59 
It is clear that in the relationship between colonoscopy quality and specialty, volume is a 
key factor. 
 
2.3 Optimal Colonoscopy Technique 
 Training endoscopists to use optimal technique is a complex, multifaceted process 
that requires close collaboration between the trainer and the trainee. Aspects of training 
that are focused upon in the CSI course include room setup, scope handling, torque 
steering, patient positioning, insufflation technique, and loop recognition and reduction. 
This section intends to highlight some techniques recently debated in the literature. 
   
2.3.1 Patient Positioning 
 Repositioning a patient during colonoscopy can facilitate insertion of the 
colonoscope and enhance visualization of the colon during withdrawal. Patient 
repositioning takes advantage of the gravity dependent distribution of fluid and air to 
optimize visualization of different colonic segments. There have been conflicting data 
published on whether prescribed patient position changes during the procedure can 
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influence ADR. 60,61 In one study, it was not shown to make a difference in those 
endoscopists with high baseline ADRs but did improve those endoscopists with ADRs 
less than 25%. A multi-center RCT published in 2016 demonstrated increased ADR and 
APC with position change on withdrawal.62 
 
2.3.2 Insertion Technique 
 Water exchange, water immersion, CO2 and air insufflation are different methods 
used to aid colonoscope insertion. The water exchange method involves infusion and 
removal of water predominantly during insertion. Using the water immersion technique, 
water is infused on insertion and removed during withdrawal. CO2 and air insufflation 
also allow for visualization of the colonic mucosa on insertion. 
 Head to head comparison of air insufflation and water infusion has shown that 
water infusion can achieve significantly higher ADRs. 63 Water infusion colonoscopy has 
also been reported to reduce discomfort and to decrease the need for patient position 
change on insertion. 64,65 When comparing air and CO2 insufflation, CO2 significantly 
reduces abdominal pain during and following colonoscopy, lasting up to 24 hours. 66 CO2 
is more readily absorbed than air and use of CO2, for both insertion and withdrawal is 
commonly recommended.  
 
2.3.3 Magnetic Endoscopic Imaging 
 Magnetic endoscopic imaging (MEI) was first described in 1993 as a measure to 
improve appreciation of colonoscopic positioning. 67 MEI provides real-time three-
dimensional views of the colonoscope configuration, allowing for identification of 
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looping during colonoscopy. MEI has been shown to be of benefit in training 
inexperienced endoscopists and improves cecal intubation rate for both experienced and 
inexperienced endoscopists.68 
 Looping occurs when the colonoscope stretches and distends the colon in 
response to the endoscopists efforts to advance the scope. This often causes pain and 
discomfort for the patient and may occur in up to 91% of colonoscopies69 Looping may 
increase procedure time, as loops often need to be reduced before the scope can be 
advanced further. Reducing a loop is accomplished with a combination of patient 
repositioning, clockwise or anticlockwise torque on the shaft and withdrawal of the 
colonoscope shaft. MEI allows the endoscopist to identify the type of loop allowing 
him/her to apply the most effective reduction technique. 
 
2.4 Previous Quality Improvement Programs/Initiatives 
 Establishing quality standards has become a recent focus in colonoscopy. Many 
centers conduct regular audits of overall performance and provide endoscopists with 
report cards on their individual performance in terms of common quality indicators. In 
the past five years there have been multiple quality improvement programs implemented 
worldwide. Most programs use changes in endoscopist ADRs as the primary outcome to 
measure quality and multiple RCTs have been published as a result. This section will 
provide a brief overview of the research that has been done in this area. 
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2.4.1 Education 
 There are multiple educational strategies currently used to target quality 
improvement. An educational intervention may consist of didactic teaching, a hands-on 
approach or a combination of the two. These interventions can target a large audience at 
once or can be done on an individualized basis. The most appropriate delivery method 
may vary depending on the content and intended result. 
 A program similar to the CAG SEE program was instituted for the National CRC 
Screening program in Poland during 2012, called the Train Colonoscopy Leaders 
program. 70 The first large multicenter RCT on a quality improvement program was 
subsequently published in 2015, showing improvement in ADR for participants by 
approximately four percent. The training of 38 screening centre leaders improved the 
performance of not only the individuals, but also the performance of their centres and 
these improvements in colonoscopy performance were sustained over the course of 18 
months. 71 The intervention group in this study received a two-day intensive training 
course on skills improvement plus two half-day hands-on sessions tailored to their needs 
based on a pre-training assessment. The control group received email feedback on their 
individual pre-intervention screening colonoscopy quality indicators. Criticisms of the 
study include potential for Hawthorne effect, since leaders knew they were being 
monitored post intervention and generalizability as inclusion criteria selected only leaders 
who had a baseline ADR ≤ 25% (suboptimal performers). 
 Two smaller RCTs at the Mayo Clinic in the United Stated also showed 
improvement in ADR for endoscopists participating in both screening and surveillance 
colonoscopy after an educational intervention, called Endoscopy Quality Improvement 
 23 
Program (EQUIP). 72,73 In the original EQUIP study, 15 endoscopists were randomized 
into two groups and both groups received feedback after an initial monitoring period but 
the intervention group also had two one-hour training sessions. The first session 
discussed methods and techniques proven to increase ADR and the second session 
focused on visually distinguishing neoplastic from non-neoplastic polyps. The 
intervention group also received monthly feedback on their ADR after the course while 
the control group did not. The intervention group saw an 11% increase in ADR while the 
control group ADR remained the same. Baseline ADR was 36% for both groups. 
Criticisms of this study included randomization (two endoscopists with the lowest 
baseline ADRs were assigned to receive training), co-interventions, and small sample 
size. The EQUIP intervention group consisted of mainly younger, less experienced 
endoscopists with some of the lowest baseline ADRs. The authors did address this in 
their subgroup analysis. The intervention group also received the training plus monthly 
feedback after the course, making it difficult to determine the benefit of the educational 
module relative to the monthly feedback on ADR. 
 The second study, EQUIP-II, was a follow up on the original and included the 
same 15 endoscopists. This study showed that improvements in ADR persisted for at 
least five months following the original study. However, in EQUIP II the control group 
was offered the educational intervention on a voluntary basis and all physicians received 
quarterly feedback on ADR. Criticisms of this study include crossover of the control 
group into the intervention group and a small sample size. The authors noted that APC 
rate did not change despite the study focusing on ADR, citing the possibility of a 'one and 
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done' phenomenon where endoscopists may not be as diligent about seeking additional 
adenomas after the first adenoma was found.73 
 
2.4.2 Audit  
 A systematic review analyzing interventions to improve ADR in 2011 included 
seven papers and ten abstracts. 74 Only one study used a randomized, controlled trial 
design; 75 others used observational designs that contrasted adenoma and/or polyp 
detection rates before, during or after the intervention. Interventions across the studies 
varied but most were focused around providing feedback to endoscopists and lengthening 
withdrawal time by setting protocols. Only one paper showed improvement in ADR, 
which was attributed to a mandated withdrawal time ≥ eight minutes paired with training 
on enhanced mucosal inspection techniques. 40 The RCT included was the Evaluation of 
Formal Feedback on Endoscopic Competence (EFFECT) trial, demonstrating improved 
cecal intubation in gastroenterology trainees who received formal feedback versus those 
without feedback. 
 Audit and feedback interventions via physician report cards continue to be 
proposed as a strategy to improve colonoscopy quality. Physician report cards provide 
feedback on a number of quality metrics and are administered at regular intervals during 
the year. They are easy to produce if the unit has an electronic medical record and can be 
low cost. Implementation of an audit and feedback system must be thoughtful with 
attention paid to the concerns of recipients in order to achieve buy in because without 
accountability or motivation to change, they may have little or no impact. 76 A recent 
study combined audit and feedback with implementing standards of practice and saw 
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significant ADR improvement. 77 Standards of practice included minimum withdrawal 
times and minimum ADRs. These are similar to what has been done in the past. Another 
review on audit and feedback interventions cited mixed results with this technique in the 
past, largely due to study designs. 78  
 
2.4.3 Endoscopy Unit Review 
 In addition to studies on education-based quality improvement programs for 
endoscopists, there has been a mixed-methods review of quality improvement for 
colonoscopy in general, involving endoscopists as well as nurses, managers and patients. 
79 The main findings of this review indicate that all user groups should be involved in the 
quality improvement process to ensure the appropriateness of the program and also that 
standards and guidelines must be reviewed and adapted locally to ensure feasibility. 
Considering patients as partners in the quality improvement process remains a challenge 
and future work might see them incorporated more often. It is noted that the most 
effective quality improvement initiatives are often in groups who have receptive attitudes 
and take ownership of the quality improvement process. Additionally, the confidentiality 
of the results for individual physicians was important and the most effective programs are 
focused on improving the quality of the colonoscopy unit as a whole and not targeting 
poor performers with negative consequences.79 
 The United Kingdom (UK) has developed a program called the Global Rating 
Scale (GRS), which is a web-based self-assessment quality improvement tool that 
underpins accreditation process for endoscopy services. 80 The GRS-UK was developed 
after an audit in 2004 revealed significant deficiencies in the quality of colonoscopy 
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services being performed at that time. 81 The outputs of the GRS provide a summary of 
progress towards quality standards as detailed by the Joint Advisory Group on GI 
Endoscopy. Progress is indicated by a score given in levels (A - D) in a number of areas 
of quality. Centres must obtain level B quality indicators if they want to be involved in 
colon cancer screening in the UK. Endoscopy services are required to submit the census 
annually to apply for accreditation. 
 The CAG developed an adaptation of the GRS-UK, the GRS-C, in 2013. 81 The 
goal was to improve endoscopic services in Canada by providing endoscopy units with a 
straightforward process to review the quality of the service they provide. The GRS-C 
uses a very similar rating scale to the GRS-UK. It is hoped the use of the GRS-C will 
help improve endoscopic services in Canada as it has in the UK. 82 No published reports 
of efficacy are available at this time. 
 
2.5 CSI Course Overview 
 The CSI course was developed by CAG for all practicing endoscopists to provide 
up-skilling and improvement of colonoscopy skills. It allows for hands-on colonoscopy 
over the one-day course, with two SEE certified faculty teaching up to three delegates. 
The course was developed based on a framework for effective, efficient delivery of 
training skills in endoscopy. 83 This framework focuses on providing performance 
enhancing feedback to trainees using a structured approach and applying basic adult 
learning techniques. Educational goals are set at the beginning of the session to help align 
agendas between trainers and trainees. A dialogue continues during the hands-on 
component of the session aimed at enhancing performance and checking for 
 27 
understanding using specific language and avoiding cognitive overload. At the end of 
each hands-on case, performance enhancing feedback is provided to the trainee along 
with one or two take home messages. Feedback is given in a non-judgmental fashion 
using a conversational approach. There has been no published evaluation of this course. 
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CHAPTER 3 METHODS 
 
3.1 Literature Search 
 The PubMed, Embase, and Cochrane databases were searched to find relevant 
literature on the topics of colonoscopy quality indicators and quality improvement. 
Searches were performed using the keywords: “colonoscopy/standards” [MeSH],  
"quality indicators, health care" [Mesh], “adenoma detection” and “sedation usage” with 
the goal of finding research examining these quality measures for colonoscopy. Another 
search was done using the following keywords: “colonoscopy/standards” [MeSH] and 
“quality improvement” [MeSH] with the goal of identifying studies examining 
colonoscopy quality improvement programs. These searches revealed 687 and 77 English 
results published in the last five years, respectively. Relevant articles were then selected 
after reviewing all abstracts and only full publications were included. Seventeen articles 
with reference to colonoscopy quality indicators were identified which consisted of 
prospective and retrospective cohorts as well as review articles. Seven quality 
improvement articles were identified and included two randomized control trials (RCT), 
one follow up study, one systematic review, one prospective cohort studies and two 
review articles. The only limits placed on the literature search were published within the 
last five years and English only publications. Bibliographies of all selected studies were 
then screened to identify any additional resources missed in the original literature search.  
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3.2 Study Design 
 This was a retrospective cohort study designed to evaluate the impact of the CAG 
CSI course on colonoscopy quality in St. John's, NL. In October 2014, 3 Eastern Health 
endoscopists began training with the SEE program. This consisted of each completing the 
CSI and TET courses themselves and then leading CSI courses under the supervision of 
certified SEE faculty. After leading six courses, the EH endoscopists received CAG 
certification to provide courses independently. Subsequently, more CSI courses were 
offered to endoscopists throughout NL. Approximately eight courses were offered each 
year, with three endoscopists attending each one. 
 Our study included all local endoscopists who had taken the CSI course up until 
May 2016, including the three endoscopists that became certified SEE faculty. Short-term 
impacts were studied by looking at fifty procedures immediately before and after CSI 
training. An additional fifty procedures were then sampled eight months after training to 
identify the durability of any short-term effects. 
 Patients were identified using the EndoProse software package in the endoscopy 
unit at our institution. Colonoscopy procedures were selected based on the date of CSI 
training for each individual endoscopist. Data were collected from multiple sources 
including the software package and the Meditech system used at both hospitals. Data 
collected were converted into an excel document directly. Once collected, all data were 
entered into SPSS version 19.0 software for statistical analysis.84 
 Full approval was obtained from the provincial Health Research Ethics board 
(File no. 20170008). Local endoscopists were aware of the study. 
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3.2.1 Outcomes Measurements 
 The primary quality outcome was ADR. Secondary outcomes included APC, 
cecal intubation rate/completion, sedation usage and dosing, and withdrawal time. 
Pathology reports were used to classify polyp histologic type and determine ADR and 
APC. Cecal intubation was determined by review of the procedure report only. 
Withdrawal time in the procedure report included any intervention, where required. 
 Data were collected on patient age, gender and indication for procedure. Data 
regarding endoscopist experience, annual colonoscopy volume and specialty 
(gastroenterology or general surgery) were collected. 
 Adequacy of bowel preparation was also recorded from the endoscopy reports. 
Bowel preparation was not assessed using a standardized tool in the procedure reports. It 
was reported using a Likert scale. 
 
3.2.2 Inclusion/Exclusion Criteria 
 We included fifty colonoscopies immediately before, immediately after and eight 
months after CSI training for each endoscopist who completed the CSI course. All 
procedures were included except those with indication 'Fecal immunochemical test (FIT) 
positive' since FIT positive patients have a higher prevalence of both CRC and adenomas 
which would bias the results. Procedures included screening and surveillance 
colonoscopies as well as diagnostic procedures based upon patient symptoms or 
abnormal laboratory and/or imaging studies. 
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3.3 Statistical Analysis 
 Students t test, chi squared tests, ANOVA and generalized linear effects model 
were used, where appropriate, to analyse the data. Students t test and ANOVA were used 
to assess continuous variables. Chi squared tests were used to assess categorical 
variables. We performed univariate analysis to identify factors associated with outcomes 
of interest including ADR, APC, procedure completion and medication dosing using a 
significance level of 0.10 as the cut-off. We then used logistic and linear regressions to 
identify factors independently associated with outcomes of interest, using a significance 
level of 0.05. 
 
3.3.1 Sample Size Determination 
 In our analysis, the primary outcome was ADR before and after completion of the 
SEE program.  
 Baseline ADR for the endoscopist group in St. John's NL is 21.8% based on 
previous work. 54 We considered an absolute ADR improvement of six percent as 
clinically meaningful based on previous literature. 71 A sample size of 826 procedures per 
time point provides 80% power to detect a proportional difference in ADR improvement 
of six percent with a two-sided significance level (α) of 0.05. We planned to include 19 
endoscopists with 50 procedures in each of the pre, post and late post groups.  
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CHAPTER 4 RESULTS 
 
4.1 Endoscopist and Patient Characteristics 
 Of the 19 endoscopists included in the study, two were excluded in the final 
analysis. One had no logged procedures prior to taking the CSI course so there was no 
baseline comparison. The other had no data in the EMR due to a technical issue with that 
individuals' procedure logging. Additionally, one endoscopist only had 33 procedures 
before taking the course but was still included in the study. Data were collected on 2533 
colonoscopies in total (833 pre CSI training, 850 immediately after CSI training and 850 
eight months after CSI training). 
 Endoscopists predominantly had more than five years of experience and were a 
combination of gastroenterologists and general surgeons (Table 1). Annual case volume 
ranged from 64 procedures per year to 800 procedures per year. The majority of general 
surgeons had an annual volume of less than 300 procedures and most gastroenterologists 
had greater than 300 procedures. 
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Table 1 Baseline Characteristics of Endoscopists 
Male sex - n (%) 12 (70.5) 
Specialty - n (%) 
Gastroenterology 
General Surgery 
 
8 (47.1) 
9 (52.9) 
Annual case volume - n (%) 
≤150 
150-300 
301-599 
≥ 600 
 
4 (23.7) 
6 (34.9) 
4 (23.7) 
3 (17.8) 
Colonoscopy experience - n (%) 
≥ 5 years 
< 5 years 
 
13 (76.5) 
4 (23.5) 
 
 
 Patient groups and indications for procedure were comparable at the pre, post 
and eight month follow up time points (Table 2). There was a statistically significant 
difference in the proportion of male patients between time points (p=0.042). The most 
common indications for colonoscopy were 'colon cancer screening' and 'history of 
polyps.'  There was a significant difference noted in the number of screening procedures 
between groups (p=0.039). There were numerous stated procedural indications. For the 
purposes of statistical analysis, we re-categorized all indications into two categories: 
screening/surveillance procedures and diagnostic procedures. 
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Table 2 Patient Characteristics and Procedure Indications 
Variable Pre CSI Post CSI 8-months p value 
Patient variables 
Age, mean (±SD) 
Male sex - n (%) 
 
60.1(12.5) 
359 (43.1) 
 
60.4(12.6) 
418 (49.2) 
 
60.5(13.0) 
387 (45.5) 
 
0.865 
0.042 
ASA Score 
1 - Normal healthy 
2 - Mild systemic disease 
3 - Severe systemic disease  
4 - Severe systemic disease 
that is a constant threat to life 
Total colonoscopies - n (%) 
Procedure indication - n (%) 
Not stated 
Colon cancer screening 
Known or suspected IBD 
Diverticulitis follow up 
History of CRC 
History of polyps 
Know carrier of a genetic CRC 
syndrome      
Abnormal imaging/Unknown 
primary/Rectal mass 
Lower GI bleed 
Non-specific lower GI symptom 
Anemia/FOB+ 
 
95 (26.2) 
225 (62.0) 
34 (9.4) 
9 (2.5) 
 
833 
 
2 (0.2) 
288 (34.6) 
54 (6.5) 
14 (1.7) 
54 (6.5) 
150 (18.0) 
6 (0.7) 
 
32 (3.8) 
 
85 (10.2) 
93 (11.2) 
55 (6.6) 
 
73 (20.9) 
231 (66.0) 
42 (12.0) 
4 (1.1) 
 
850 
 
2 (0.2) 
245 (28.8) 
66 (7.8) 
20 (2.4) 
66 (7.8) 
160 (18.8) 
5 (0.6) 
 
33 (3.9) 
 
94 (11.1) 
104 (12.2) 
55 (6.5) 
 
70 (22.2) 
205 (64.9) 
37 (11.7) 
4 (1.3) 
 
850 
 
6 (0.7) 
273 (32.1) 
54 (6.4) 
14 (1.6) 
59 (6.9) 
151 (17.8) 
12 (1.4) 
 
33 (3.9) 
 
86 (10.1) 
99 (11.6) 
63 (7.4) 
 
0.051 
0.272 
0.682 
0.210 
 
 
 
0.207 
0.039 
0.446 
0.486 
0.582 
0.839 
0.185 
 
0.999 
 
0.783 
0.791 
0.707 
 
 
 The American society of Anesthesiologists (ASA) score was recorded for only 
1029 procedures. This score assesses the physical status of a patient before a procedure. 
The score ranges from one to six. A score of one represents a normal healthy patient 
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while a score of six represents a patient with declared brain death. There was no 
significant difference noted in ASA scores between groups (Table 2). 
   
4.2 Procedural and Quality Outcomes 
  
4.2.1 Bowel Preparation 
 For the purposes of our analysis bowel preparations were either considered 
'adequate' or 'inadequate.' An 'adequate' preparation was rated as either excellent or good 
in the procedure record. 'Inadequate' preparations were those rates as poor and very poor. 
There was a significant difference in both adequacy of bowel preparations and type of 
bowel preparations used at the different time points (Table 3). We believe this change 
represents a change in practice of the group that occurred over the course of our study, 
independent of the training course itself. Adequacy of bowel preparation was kept in all 
multivariate analyses to account for any effect caused by this change.  
 
Table 3 Bowel Preparation 
Variable Pre CSI Post CSI 8-months p value 
Adequate preparation - n (%) 
Type of preparation - n (%) 
Golytely 
Peglyte 
Picosalax 
Purgodan 
Not noted/Other 
419 (50.3) 
 
360 (43.2) 
59 (7.1) 
284 (34.1) 
3 (0.4) 
127 (15.2) 
450 (52.9) 
 
372 (43.8) 
78 (9.2) 
238 (28.0) 
7 (0.8) 
155 (18.2) 
614 (72.2) 
 
410 (48.2) 
204 (24.0) 
77 (9.1) 
9 (1.1) 
150 (17.7) 
0.000 
 
0.075 
0.000 
0.000 
0.240 
0.226 
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4.2.2 Withdrawal Time 
 Withdrawal time was recorded for 2320 (91.6%) of cases. Of those, 1333 
procedures had some sort of intervention (e.g. polypectomy, biopsy), excluding them 
from our analysis of withdrawal time. In the baseline group 337 procedural withdrawal 
times were included with a mean withdrawal time of 8.64 minutes. Immediately 
following CSI training withdrawal time was included for 326 procedures and increased 
non-significantly to 8.77 minutes (P=0.599).  At the eight month follow up withdrawal 
times for 324 procedures were included and the mean was 8.35 minutes (P=0.236). Since 
only 1200 of 2533 procedures included in the study had withdrawal times representing 
inspection time, withdrawal time was not included in regression analyses. Withdrawal 
time was above the minimum standard for quality for all groups. 
 
4.2.3 Adenoma Detection Rate 
 Univariate and multivariate regression analysis was performed to identify 
variables independently associated with ADR. Univariate analysis was completed with 
chi squared tests and ANOVA using a cut-off of p=0.10. Variables associated with ADR 
in univariate analysis included patient age, patient gender, Fentanyl and Midazolam 
dosing, as well as procedure indication (Table 4). 
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Table 4 Univariate Analysis for ADR 
Variable Adenoma Detection p value 
Mean patient age (years) 
Adenoma detected 
Adenoma not detected 
Fentanyl dose (mcg) 
Adenoma detected 
Adenoma not detected 
Midazolam dose (mg) 
Adenoma detected 
Adenoma not detected 
Gender (%) 
Female 
Male 
Adequacy of bowel preparation (%) 
Adequate 
Inadequate 
Preparation type (%) 
Golytely 
Peglyte 
Picosalax 
Purgodan 
Specialty (%) 
General Surgery 
Gastroenterology 
CSI training (%) 
Pre 
Post 
8 months 
Indication (%) 
Screening/Surveillance 
Diagnostic 
 
63.92 
58.25 
 
63.8 
68.7 
 
2.13 
2.32 
 
27.6 
40.6 
 
34.3 
32.6 
 
34.7 
33.1 
33.4 
21.1 
 
33.3 
33.9 
 
31.8 
33.6 
35.3 
 
39.3 
25.8 
 
 
 
 
 
<0.001 
 
 
<0.001 
 
 
<0.001 
 
 
<0.001 
 
 
0.358 
 
 
0.215 
 
 
 
 
0.764 
 
 
0.131 
 
 
 
<0.001 
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Adequacy of bowel preparation was not significantly associated with ADR in univariate 
analysis but was included in the multivariate model as we saw a change in adequacy of 
preparations over time. Multivariate analysis was performed using binary logistic 
regression. Variables associated with ADR in the multivariate analysis included patient 
age, male gender, and indication screening/surveillance (Table 5). R square value for the 
model was 0.108. 
 
Table 5 Multivariate Logistic Regression Model for ADR 
Variable Odds ratio 95% confidence interval p value 
Age 
Gender 
Female 
Male 
Indication 
Diagnostic 
Screening/Surveillance 
 
 
1.039 
 
Reference 
1.704 
 
Reference 
1.860 
 
1.031 - 1.046 
 
 
1.435 - 2.023 
 
 
1.556 - 2.223 
 
<0.001 
 
 
<0.001 
 
 
<0.001 
 
 The overall ADR for endoscopists in the pre-training group was 31.8%. There 
was a non-significant increase in ADR to 33.6% after CSI training (P=0.423) with a 
further but non-significant increase at eight months to 35.5% (P=0.131) (Table 6). 
Endoscopists were broken into quartiles based on ADR at the pre-training time point. 
Endoscopists in the lowest ADR quartile (Q1), had an overall pre-training ADR of 21.3%. 
This increased non-significantly to 26.0% (P=0.282) immediately following training and 
increased further to 27.5% at eight months but still remained non-significant (P=0.160). 
We would expect to see the most pronounced change in the lowest ADR quartile as they 
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often have the most room to improve. Similar but less pronounced, non-significant 
changes were seen in the remainder of the ADR quartiles. The general surgery group had 
a baseline ADR of 30.9% and showed a non-significant increase to 31.6% (P=0.829) 
immediately after training and significantly increased to 37.6% (0.035) at the eight month 
mark. Specialty, however, was not a significant predictor of ADR in univariate analysis 
(Table 4). The gastroenterology group had a slightly higher baseline ADR at 32.9 % that 
increased non-significantly to 36.0% immediately after CSI training (P=0.368). This 
increase in ADR did not persist at the eight month mark 32.8% (P=1.00). Variables 'ADR 
quartile' and 'specialty' were derived from the endoscopist variable. As such only one 
could be used in the regression analysis to prevent multicollinearity. Multicollinearity is a 
phenomenon in which one predictor variable in a multiple regression model can be 
linearly predicated from the others with a substantial degree of accuracy. A multivariate 
regression model with colinear predictors can still indicate how well the entire bundle of 
predictors predict the outcome variable but may not give valid results about any 
individual predictor. We chose specialty as it had the most clinical relevance. 
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Table 6 Procedural Quality Outcomes by Time Point 
Variable Pre CSI Post CSI 8-months p value 
ADR - n (%) 
ADR by quartile (%) 
Q1 (≤24%) 
Q2 (25%-31%) 
Q3 (32%-35%) 
Q4 (≥36%) 
ADR by specialty - n (%) 
General Surgery 
Gastroenterology 
APC - mean (±SE) 
Completion rate - n (%) 
PDR - n (%) 
Sedation used - n (%) 
Sedation dosing - mean (±SE) 
Fentanyl 
Midazolam 
265 (31.8) 
 
21.3 
28.5 
32.7 
40.0 
 
139 (30.9) 
126 (32.9) 
0.64 (0.05) 
94.1 
415 (31.6) 
805 (96.6) 
 
72.8 (1.1) 
2.49 (0.03) 
286 (33.6) 
 
26.0 
29.5 
36.7 
40.0 
 
142 (31.6) 
144 (36.0) 
0.74 (0.05) 
94.2 
451 (34.4) 
812 (95.5) 
 
64.8 (1.1) 
2.17 (0.03) 
300 (35.3) 
 
27.5 
33.0 
30.0 
44.7 
 
169 (37.6) 
131 (32.8) 
0.70 (0.05) 
94.7 
446 (34.0) 
820 (96.5) 
 
63.5 (0.9) 
2.11 (0.03) 
0.131 
 
0.160 
0.329 
0.467 
0.247 
 
0.035 
0.361 
0.284 
0.858 
0.368 
0.437 
 
<0.001 
<0.001 
 
 
 Given that there appeared to be an association between ADR and CSI training for 
surgeons, we performed a subgroup analysis for this cohort of patients. We found the 
eight month time point following CSI training was associated with increased ADR for 
surgeons when accounting for patient age, gender, preparation adequacy and procedure 
indication (Table 7). 
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Table 7 Multivariate Logistic Regression Model for ADR for Surgeons 
Variable Odds ratio 95% confidence interval p value 
Age 
Gender 
Female 
Male 
Indication 
Diagnostic 
Screening/Surveillance 
8 months post CSI 
1.036 
 
Reference 
1.680 
 
Reference 
1.471 
1.309 
1.026 - 1.047 
 
 
1.329 - 2.123 
 
 
1.159 - 1.869 
1.025 - 1.672 
<0.001 
 
 
<0.001 
 
 
0.002 
0.031 
 
 
4.2.4 Adenomas Per Colonoscopy 
 Mean number of adenomas detected per colonoscopy showed non-significant 
changes immediately after CSI training and at the eight month mark (Table 6). 
 Univariate and multivariate regression analyses were performed to identify 
variables independently associated with APC. Univariate analysis was completed using 
ANOVA and correlations with a cut-off of p=0.10. Variables associated with APC in 
univariate analysis included patient age, patient gender, Midazolam dose, and indication 
(Table 8). 
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Table 8 Univariate Analysis for APC 
Variable    Correlation coefficient p value 
Mean patient age (years) 
Pearson correlation coefficient 
Fentanyl dose (mcg) 
Pearson correlation coefficient 
Midazolam dose (mg) 
Pearson correlation coefficient 
 
Variable 
    
0.193 
 
-0.050 
     
-0.069 
 
APC rate 
 
<0.001 
 
0.012 
 
0.001 
 
p value 
Gender  
Female 
Male 
Adequacy of bowel preparation  
Adequate 
Inadequate 
Preparation type  
Golytely 
Peglyte 
Picosalax 
Purgodan 
Specialty  
General Surgery 
Gastroenterology 
CSI training  
Pre 
Post 
8 months 
Indication  
Screening/Surveillance 
Diagnostic 
 
0.51 
0.91 
 
0.67 
0.73 
 
0.68 
0.65 
0.69 
0.26 
 
0.67 
0.72 
 
0.64 
0.74 
0.70 
 
0.80 
0.55 
 
 
 
 
 
<0.001 
 
 
0.321 
 
 
0.156 
 
 
 
 
0.764 
 
 
0.284 
 
 
 
<0.001 
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Adequacy of preparation was again included in the model. Multivariate analysis was 
conducted using linear regression. Factors associated with APC in multivariate analysis 
included patient age, male gender, and screening/surveillance procedure (Table 9). R 
square value associated with the model was 0.059. 
 
Table 9 Multivariate Linear Regression Model for APC 
Variable B 95% confidence interval p value 
Constant 
Age 
Female gender 
Diagnostic procedure 
0.351 
0.020 
-0.359 
-0.216 
0.002 - 0.669 
0.016 - 0.024 
-0.465 - -0.253 
-0.323 - -0.109 
0.049 
<0.001 
<0.001 
<0.001 
 
 
4.2.5 Completion 
 Completion rate for all procedures included in the study was 94.4%. There was no 
significant difference between procedure completion rates based on CSI training (Table 
6).  
 Univariate and multivariate regression analysis was performed to identify 
variables associated with procedure completion. Univariate analysis was performed with 
chi squared tests and ANOVA using a cut-off of p=0.10. Variables associated with 
procedure completion in univariate analysis included patient age, patient gender, Fentanyl 
dose, specialty and indication (Table 10). 
 
 44 
Table 10 Univariate Analysis for Completion 
Variable  Completion p value 
Mean patient age (years) 
Procedure complete 
Procedure incomplete 
Fentanyl dose (mcg) 
Procedure complete 
Procedure incomplete 
Midazolam dose (mg) 
Procedure complete 
Procedure incomplete 
Gender (%) 
Female 
Male 
Adequacy of bowel preparation (%) 
Adequate 
Inadequate 
Specialty (%) 
General Surgery 
Gastroenterology 
Indication (%) 
Screening/Surveillance 
Diagnostic 
 
59.97 
63.24 
 
66.6 
74.5 
 
2.25 
2.33 
 
93.1 
95.9 
 
94.8 
93.7 
 
92.7 
96.3 
 
96.0 
92.1 
 
 
 
 
 
0.003 
 
 
0.003 
 
 
0.333 
 
 
0.002 
 
 
0.240 
 
 
<0.001 
 
 
<0.001 
 
 
Adequacy of preparation was again included in the model. Multivariate analysis was 
completed using binary logistic regression, identifying male gender, 
screening/surveillance indication and gastroenterology specialty as significantly 
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associated with procedure completion. Patient age and Fentanyl dosage were inversely 
related to completion rate (Table 11). R square value for the model was 0.061. 
 
Table 11 Multivariate Logistic Regression Model for Completion 
Variable Odds ratio 95% confidence interval p value 
Age 
Fentanyl dose 
Gender 
Female 
Male 
Indication 
Diagnostic 
Screening/Surveillance 
Specialty 
General Surgery 
Gastroenterology 
0.975 
0.993 
 
Reference 
1.684 
 
Reference 
1.948 
 
Reference 
1.749 
0.961 - 0.990 
0.988 - 0.999 
 
 
1.169 - 2.426 
 
 
1.378 - 2.754 
 
 
1.196 - 2.557 
0.001 
0.021 
 
 
0.005 
 
 
<0.001 
 
 
0.004 
 
 
4.2.6 Sedation Dosing 
 Sedation was given in 96.2% of cases. The only two medications used for 
sedation were Fentanyl and Midazolam. Sedation dosing decreased significantly for both 
Fentanyl and Midazolam after CSI training. This effect persisted at the eight month 
follow up (Table 6). 
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4.2.6.1 Fentanyl 
 Univariate and multivariate regression analysis was performed to identify 
variables associated with Fentanyl dosing. Univariate analysis was completed using 
ANOVA and correlations with a cut-off of p=0.10. Variables associated with Fentanyl 
dose in univariate analysis included CSI training, patient gender, patient age, specialty, 
procedure completion, polypectomy, and indication (Table 12). 
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Table 12 Univariate Analysis for Fentanyl Dose 
Variable    Correlation coefficient p value 
Mean patient age (years) 
Pearson correlation coefficient 
 
Variable 
    
-.225 
     
Fentanyl dose (mcg) 
 
<0.001 
 
p value 
Gender 
Female 
Male 
Adequacy of bowel preparation 
Adequate 
Inadequate 
Specialty 
General Surgery 
Gastroenterology 
CSI training 
Pre 
Post 
8 months 
Indication 
Screening/Surveillance 
Diagnostic 
Procedure Completion 
Complete 
Incomplete 
Polypectomy 
Yes 
No 
 
71.7 
61.5 
 
67.1 
66.8 
 
72.6 
60.6 
 
72.8 
64.8 
63.5 
 
65.6 
69.0 
 
30.2 
36.5 
 
64.4 
69.6 
 
 
 
 
 
<0.001 
 
 
0.786 
 
 
<0.001 
 
 
<0.001 
 
 
 
0.006 
 
 
0.003 
 
 
<0.001 
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 Multivariate analysis was conducted using linear regression. Variables associated 
with Fentanyl dose included CSI training, patient age, patient gender, procedure 
completion and specialty (Table 13). R square value for the model was 0.141. 
 
Table 13 Multivariate Linear Regression Model for Fentanyl Dose 
Variable B 95% confidence interval p value 
Constant 
Age 
Female gender 
Gastroenterology specialty 
Complete procedure 
Immediate post CSI 
8 months post CSI  
141.708 
-0.587 
9.254 
-13.756 
-6.156 
-7.197 
-8.917 
127.908 - 155.508 
-0.675 - -0.498 
7.024 - 11.484 
-15.992 - -11.520 
-10.974 - -1.338 
-9.911 - -4.484 
-11.628 - -6.206 
<0.001 
<0.001 
<0.001 
<0.001 
0.012 
<0.001 
<0.001 
 
 
4.2.6.2 Midazolam 
 Univariate and multivariate regression analysis was performed to identify 
variables associated with Midazolam dosing. Univariate analysis was completed using 
ANOVA and correlations with a cut-off of p=0.10. Variables associated with Midazolam 
dosing in univariate analysis included CSI training, patient gender, patient age, specialty, 
and polypectomy (Table 14). 
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Table 14 Univariate Analysis for Midazolam Dose 
Variable    Correlation coefficient p value 
Mean patient age (years) 
Pearson correlation coefficient 
 
Variable 
    
-.215 
     
Midazolam dose (mg) 
 
<0.001 
 
p value 
Gender 
Female 
Male 
Adequacy of bowel preparation 
Adequate 
Inadequate 
Specialty 
General Surgery 
Gastroenterology 
CSI training 
Pre 
Post 
8 months 
Indication 
Screening/Surveillance 
Diagnostic 
Procedure Completion 
Complete 
Incomplete 
Polypectomy 
Yes 
No 
 
2.39 
2.10 
 
2.25 
2.27 
 
2.29 
2.21 
 
2.49 
2.17 
2.11 
 
2.23 
2.29 
 
0.95 
1.18 
 
2.18 
2.33 
 
 
 
 
 
<0.001 
 
 
0.606 
 
 
0.025 
 
 
<0.001 
 
 
 
0.104 
 
 
0.333 
 
 
<0.001 
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 Multivariate analysis was conducted using linear regression. Variables associated 
with Midazolam dosing included CSI training, patient age, patient gender and specialty 
(Table 15). R squared value for the model was 0.096. 
 
Table 15 Multivariate Linear Regression Model for Midazolam Dose 
Variable B 95% confidence interval p value 
Constant 
Age 
Female gender 
Gastroenterology specialty 
Immediate post CSI 
8 months post CSI  
3.925 
-0.016 
0.257 
-0.139 
-0.294 
-0.370 
3.606 - 4.244 
-0.019 - -0.013 
0.185 - 0.328 
-0.211 - -0.067 
-0.382 - -0.207 
-0.457 - -0.283 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
 
 Given the association between gastroenterology specialty and sedation dosing, we 
performed subgroup analysis for both gastroenterologists and general surgeons. Both 
groups had significant decreases in sedation dosing at the immediate post and eight 
month time points. 
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CHAPTER 5 DISCUSSION 
 
5.1 Quality Outcomes 
 This was the first formal evaluation of the impact of CAG CSI program on 
colonoscopy quality. Although we noted trends towards improvement in ADR there was 
no statistically significant association between ADR and CSI training for the entire group 
(Table 6). When we looked at endoscopists in the lowest ADR quartile we saw the same 
non-significant trend towards improvement in ADR. The subgroup analysis for general 
surgeons showed a significant improvement in ADR at the eight month time point. This 
finding suggests that the surgical group (lower volume endoscopists with less formal 
colonoscopy training) benefit more from CSI training than their colleagues in 
gastroenterology. One can only speculate why this occurred. 
 Based on previous work, overall ADR for our institution was 21.8% in 2012. 54 At 
the pre CSI training time point in our study, ADR was 31.8%. There had clearly been a 
significant improvement before the initiation of CSI training. We noted multiple practice 
changes over that time period. The endoscopy vendor changed from Fujinon to Olympus 
in 2014 and this included the addition of magnetic imaging. There had also been a change 
to split dose bowel preparation. Also, educational initiatives were undertaken to improve 
colonoscopy quality along with the introduction of the GRS-C. All of these factors may 
have influenced ADR. In addition, given that all endoscopists were aware their outcomes 
were being monitored, the Hawthorne effect may have played a role in the improvements 
seen between 2012 and the baseline measurements used for our study. 
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 A possible explanation why the current study did not document significant 
changes in ADR for the entire group of endoscopists is the high baseline ADR. The 
accepted guideline for ADR in average risk patients is 25%, much lower than the baseline 
ADR for this group. Another possible explanation may be the CSI course itself. The 
training that occurs focuses more on helping the trainees navigate the colonoscope to the 
cecum in an ergonomic fashion that is comfortable for the patient. Although discussed, 
less emphasis is placed on finding and removing polyps. 
 No significant association was demonstrated between CSI training and APC. APC 
did show a non-significant trend towards improvement immediately after CSI training 
and remained higher at the eight month time point (Table 6). As expected, we noted 
patient age, patient gender and procedure indication to be associated with APC in 
multivariate analysis. 
 During the time period of our study we noted significant changes in bowel 
preparation type and quality. This likely reflects a practice change of the entire group 
towards split dose preparation given recent evidence of superiority. 42 This was included 
in all multivariate analyses since it is known to affect ADR and may affect other quality 
outcomes of interest. An improvement in bowel preparation could confound our results, 
biasing towards a higher ADR at eight months and potentially lead to false positive 
results. 
 No association was identified between procedure completion as defined by cecal 
intubation and CSI training. Our group had a high completion rate at the baseline time 
point of 94.1%. This is well above the acceptable standard of 90%.25 Completion rate was 
higher in the gastroenterology group, which may again be attributed to the fact that most 
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general surgeons at our institution have a lower annual volume and the general surgery 
group contains more endoscopists with less than five years of experience. 
 CSI training appears to have improved quality at our institution primarily through 
reduced sedation dosing for both Fentanyl and Midazolam. These are the only two 
sedation agents used for colonoscopy at our institution. This change in practice persisted 
at the eight month time point. 
 The association between lower sedation dosing and CSI training may reflect 
improvement in colonoscopy technique associated with taking the course. The course 
focused on topics including scope handling, torque steering, patient positioning, 
insufflation technique, and loop recognition and reduction. All of these topics are 
discussed to help lessen patient discomfort and sedation requirements.49 
 Specifically, frequent patient repositioning is emphasized during the course, with 
a goal of having the patient in optimal position for colonoscope insertion and mucosal 
inspection in each segment of colon. This is a relatively new technique that most local 
endoscopists had not adopted prior to taking the course. To allow for frequent 
repositioning it is helpful to have an awake and alert patient that can respond to 
commands. Deep sedation would prevent this, making the repositioning much more 
difficult.  
 Less sedation may also be valuable in that it may reduce recovery time. Short 
recovery time and faster discharge is an argument provided for using propofol over a 
narcotic and benzodiazepine combination. 85 CSI training may reduce recovery and 
discharge time associated with a narcotic and benzodiazepine combination by reducing 
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doses of these agents. Although our study did not address this issue, it may be an area for 
future work. 
 Gastroenterology specialty was associated with lower Fentanyl and Midazolam 
dosing when compared to the general surgeons. The gastroenterologists at our institution 
have higher annual procedural volumes on average than the general surgeons. This fits 
with findings recently published in the UK showing that more experienced endoscopists 
use less sedation to complete the procedure. 48 In the subgroup analysis both 
gastroenterology and general surgery groups had significant reductions in sedation dosing 
after CSI training, which suggests the benefits are independent of annual volume. 
 In our multivariate models for both Fentanyl and Midazolam we demonstrated 
that there was no significant difference between mean dosage at the immediate post 
training and eight month time points. This further strengthens our findings and suggests 
that the change is related to CSI training rather than time of sampling. 
 This is the first study to show an association between an educational intervention 
to improve colonoscopy quality and lower sedation dosing. Previous studies have not 
assessed effects on sedation while focusing mainly on ADR. 71,72 A study done during 
2012 showed that medication related adverse events were extremely common. 35 In that 
study one in ten patients suffered hypoxia (oxygen saturation ≤85%) and one in six 
patients suffered hypotension (blood pressure <20% of baseline). Although we did not 
assess the rate of these adverse events, given the significant reduction in sedation it is 
likely a decrease in the incidence of these adverse events would correspond. 
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5.2 Sample Size Calculation and Power 
 The sample size calculation performed for this study estimated a total number of 
procedures necessary to detect a 6% change in ADR. Procedural data were collected 
based on the date that each individual endoscopist participated in CSI training. Because 
of this, our sample size calculation may overlook clustering and correlation of outcomes 
within individual endoscopists. This is an issue we did not consider, but an important 
consideration for future research, as it would significantly increase the sample size 
necessary to detect a change in ADR. 
 Using the same baseline ADR of 21.8% and considering an ADR improvement of 
6% as clinically meaningful, a sample size of 1330 procedures per time point would be 
necessary when accounting for correlation of outcomes using an intra-cluster correlation 
coefficient of 0.05. If we were to increase the correlation coefficient, the sample size 
would increase further. Another alternative to this would be to change our data collection 
strategy, sampling procedures at a time point before training was initiated in 2014 and 
again at the completion of all training. In this scenario, clustering and correlation of 
outcomes would not be an issue. 
 
5.3 Limitations 
 Our study has some limitations. First, this is a retrospective study and we are 
relying on endoscopist records for our data. Not all data may be entered accurately or 
completely. Second, we cannot control for all confounding variables. We did identify and 
control for bowel preparation type and adequacy as possible confounders, including these 
in the multivariate analyses. Third, our cohort of endoscopists were highly experienced, 
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13 endoscopists in our study have been in practice for over five years and only three had 
an annual volume less than 150 procedures. This may partially account for our high 
baseline ADR and completion rate. In a less experienced group we may see more 
pronounced effects with CSI training. Fourth, our sample of procedures was 
heterogeneous in terms of indication. We did however account for indication in all 
regression analyses and FIT positive procedures were excluded. Fifth, a recent audit 
performed in 2012 may have improved ADR through a Hawthorne effect, making it more 
difficult to see change in our study. Lastly, procedures for two of the nineteen 
endoscopists were not included in our study and our study may be underpowered to 
detect small changes in ADR due to correlation of outcomes within individual 
endoscopists. At our institution CSI training was provided free of cost to the individual 
which enhanced uptake of the program. 
 To avoid bias in this study we chose a clear primary outcome variable that could 
be accurately measured and has been validated in the literature. Data on all cases were 
collected in the same fashion and a sample size calculation was performed at the outset of 
the study. This study was susceptible to selection bias in choosing patients to include. We 
standardized our method of case selection for each endoscopist to minimize this. The 
only procedures excluded were those with indication FIT positive. Being a retrospective 
study, confounding is a significant potential issue. Confounding occurs when differences 
in the baseline characteristics between the study groups result in difference in the 
outcome. In our study particularly it was important to account for patient age, gender and 
bowel preparation quality, which are all variables know to influence ADR. 
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5.4 Future Work 
 Our retrospective study has identified that training aimed at increasing the skills 
of the experienced endoscopist can improve quality. The next step to evaluate the impact 
of the CSI program may be a randomized controlled trial assigning endoscopists with no 
prior CSI training to take the course or not. Such an RCT may have ethical issues and if 
ethically permissible, would have considerable logistic challenges. An argument could 
also be made that such an RCT is not actually necessary given the results of our study. 
There may also be value in repeating a similar study with a less experienced group of 
endoscopists as more pronounced effects could be noted. It would be useful to study a 
group that has not previously undergone audit as that may have impacted our results. 
Additionally, given we identified significant changes in practice with just a one-day 
course, larger effects may be achieved with more training interventions or interventions 
specifically targeting ADR improvement.  
 Given the findings of our study it may be prudent to compare patient comfort 
between endoscopists who have completed CSI training and those who have not. It would 
be important to identify whether lower levels of sedation are correlated with higher levels 
of patient discomfort. We hypothesize that lower levels of sedation actually reflects 
improved technique causing less discomfort. 
 
CONCLUSION 
 In summary, participation in CSI training was shown to be associated with 
improvements in quality, specifically with regards to sedation required. Specifically we 
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have identified that colonoscopy can be completed with less sedation in a sustained 
fashion with a brief training course. CSI training appears to improve ADR for surgeons. 
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